共 50 条
[46]
Potent anti-myeloma activity of the TOPK inhibitor OTS514 in pre-clinical models
[J].
CANCER MEDICINE,
2020, 9 (01)
:324-334
[47]
Mithramycin Exerts an Anti-Myeloma Effect and Displays Anti-Angiogenic Effects through Up-Regulation of Anti-Angiogenic Factors
[J].
PLOS ONE,
2013, 8 (05)
[48]
A novel 2-iminobenzimidazole compound, XYA1353, displays in vitro and in vivo anti-myeloma activity via targeting NF-κB signaling
[J].
Molecular and Cellular Biochemistry,
2024, 479
:843-857